Jenburkt Pharmaceuticals Ltd banner

Jenburkt Pharmaceuticals Ltd
BSE:524731

Watchlist Manager
Jenburkt Pharmaceuticals Ltd Logo
Jenburkt Pharmaceuticals Ltd
BSE:524731
Watchlist
Price: 1 000 INR 0.01% Market Closed
Market Cap: ₹4.4B

Profitability Summary

Jenburkt Pharmaceuticals Ltd's profitability score is 61/100. We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

61/100
Profitability
Score

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

61/100
Profitability
Score
61/100
Profitability
Score

Margins

Earnings Waterfall
Jenburkt Pharmaceuticals Ltd

Margins Comparison
Jenburkt Pharmaceuticals Ltd Competitors

Country Company Market Cap Gross
Margin
Operating
Margin
Net
Margin
IN
Jenburkt Pharmaceuticals Ltd
BSE:524731
4.4B INR
Loading...
Loading...
Loading...
US
Eli Lilly and Co
NYSE:LLY
932.9B USD
Loading...
Loading...
Loading...
US
Johnson & Johnson
NYSE:JNJ
578.6B USD
Loading...
Loading...
Loading...
CH
Roche Holding AG
SIX:ROG
271B CHF
Loading...
Loading...
Loading...
CH
Novartis AG
SIX:NOVN
236.2B CHF
Loading...
Loading...
Loading...
UK
AstraZeneca PLC
LSE:AZN
224.8B GBP
Loading...
Loading...
Loading...
US
Merck & Co Inc
NYSE:MRK
287.1B USD
Loading...
Loading...
Loading...
IE
Endo International PLC
LSE:0Y5F
218B USD
Loading...
Loading...
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.1T DKK
Loading...
Loading...
Loading...
US
Pfizer Inc
NYSE:PFE
153.8B USD
Loading...
Loading...
Loading...
US
Bristol-Myers Squibb Co
NYSE:BMY
121B USD
Loading...
Loading...
Loading...

Return on Capital

Return on Capital Comparison
Jenburkt Pharmaceuticals Ltd Competitors

Country Company Market Cap ROE ROA ROCE ROIC
IN
Jenburkt Pharmaceuticals Ltd
BSE:524731
4.4B INR
Loading...
Loading...
Loading...
Loading...
US
Eli Lilly and Co
NYSE:LLY
932.9B USD
Loading...
Loading...
Loading...
Loading...
US
Johnson & Johnson
NYSE:JNJ
578.6B USD
Loading...
Loading...
Loading...
Loading...
CH
Roche Holding AG
SIX:ROG
271B CHF
Loading...
Loading...
Loading...
Loading...
CH
Novartis AG
SIX:NOVN
236.2B CHF
Loading...
Loading...
Loading...
Loading...
UK
AstraZeneca PLC
LSE:AZN
224.8B GBP
Loading...
Loading...
Loading...
Loading...
US
Merck & Co Inc
NYSE:MRK
287.1B USD
Loading...
Loading...
Loading...
Loading...
IE
Endo International PLC
LSE:0Y5F
218B USD
Loading...
Loading...
Loading...
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.1T DKK
Loading...
Loading...
Loading...
Loading...
US
Pfizer Inc
NYSE:PFE
153.8B USD
Loading...
Loading...
Loading...
Loading...
US
Bristol-Myers Squibb Co
NYSE:BMY
121B USD
Loading...
Loading...
Loading...
Loading...

Free Cash Flow

Free Cash Flow Analysis
Jenburkt Pharmaceuticals Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett